Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
出版年份 2018 全文链接
标题
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-11-08
DOI
10.1038/s41467-018-06951-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
- (2018) Cristina Gutiérrez-Vázquez et al. IMMUNITY
- Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
- (2018) Supraja Narasimhan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells
- (2018) Yuying Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value
- (2018) Ángel C. Roman et al. PHARMACOLOGY & THERAPEUTICS
- Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
- (2018) Melanie Werner-Klein et al. Nature Communications
- Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
- (2017) Xiangjun Kong et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- A non-coding function of TYRP1 mRNA promotes melanoma growth
- (2017) David Gilot et al. NATURE CELL BIOLOGY
- Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells
- (2017) Natalia Kovalova et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
- (2017) Chunying Song et al. Cancer Discovery
- The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
- (2017) Kimberley Hanson et al. Oncotarget
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
- (2016) Lise Boussemart et al. CANCER RESEARCH
- MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB
- (2016) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis
- (2016) E. A. Stanford et al. MOLECULAR CANCER RESEARCH
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- BRAF V600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
- (2016) Kristel Kemper et al. Cell Reports
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2
- (2015) Sangjoo Park et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis
- (2015) María Contador-Troca et al. Molecular Cancer
- RAF inhibitors that evade paradoxical MAPK pathway activation
- (2015) Chao Zhang et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
- (2015) Ryan B. Corcoran et al. Oncotarget
- Ligand Promiscuity of Aryl Hydrocarbon Receptor Agonists and Antagonists Revealed by Site-Directed Mutagenesis
- (2014) A. A. Soshilov et al. MOLECULAR AND CELLULAR BIOLOGY
- p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
- (2014) Amine Bouafia et al. PLoS Genetics
- Aryl Hydrocarbon Receptor Activation by Dioxin Targets Phosphoenolpyruvate Carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly(ADP-ribose) Polymerase (TiPARP)
- (2013) Silvia Diani-Moore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
- (2013) Stephen Safe et al. TOXICOLOGICAL SCIENCES
- A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein
- (2012) Chi Tze Tiong et al. CARCINOGENESIS
- Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor
- (2012) J. Brooks et al. CURRENT CANCER DRUG TARGETS
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNAi-Based Screening Identifies Kinases Interfering with Dioxin-Mediated Up-Regulation of CYP1A1 Activity
- (2011) David Gilot et al. PLoS One
- The aryl hydrocarbon receptor: fine-tuning the immune-response
- (2010) Marc Veldhoen et al. CURRENT OPINION IN IMMUNOLOGY
- The Aryl Hydrocarbon Receptor Mediates UVB Radiation–Induced Skin Tanning
- (2010) Bettina Jux et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609)
- (2008) P. Monteiro et al. DRUG METABOLISM AND DISPOSITION
- Cyclical DNA methylation of a transcriptionally active promoter
- (2008) Raphaël Métivier et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More